BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 26825883)

  • 1. Role of the Intravoxel Incoherent Motion Diffusion Weighted Imaging in the Pre-treatment Prediction and Early Response Monitoring to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
    Che S; Zhao X; Ou Y; Li J; Wang M; Wu B; Zhou C
    Medicine (Baltimore); 2016 Jan; 95(4):e2420. PubMed ID: 26825883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of intravoxel incoherent motion diffusion-weighted imaging in predicting the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.
    Song T; Yao Q; Qu J; Zhang H; Zhao Y; Qin J; Feng W; Zhang S; Han X; Wang S; Yan X; Li H
    Eur Radiol; 2021 Mar; 31(3):1391-1400. PubMed ID: 32901300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative intravoxel incoherent motion parameters derived from whole-tumor volume for assessing pathological complete response to neoadjuvant chemotherapy in locally advanced rectal cancer.
    Xu Q; Xu Y; Sun H; Chan Q; Shi K; Song A; Wang W
    J Magn Reson Imaging; 2018 Jul; 48(1):248-258. PubMed ID: 29281151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravoxel Incoherent Motion-Magnetic Resonance Imaging as an Early Predictor of Treatment Response to Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma.
    Xiao Y; Pan J; Chen Y; Chen Y; He Z; Zheng X
    Medicine (Baltimore); 2015 Jun; 94(24):e973. PubMed ID: 26091468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of diffusion weighted imaging (DWI) in evaluating early response to neoadjuvant chemotherapy in locally advanced breast cancer].
    Wang XH; Peng WJ; Tan HN; Xin C; Gu YJ; Tang F; Mao J
    Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):377-81. PubMed ID: 20723438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the Apparent Diffusion Coefficient in the Prediction of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer.
    Bufi E; Belli P; Costantini M; Cipriani A; Di Matteo M; Bonatesta A; Franceschini G; Terribile D; Mulé A; Nardone L; Bonomo L
    Clin Breast Cancer; 2015 Oct; 15(5):370-80. PubMed ID: 25891905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Value of 18F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
    Luo J; Zhou Z; Yang Z; Chen X; Cheng J; Shao Z; Guo X; Tuan J; Fu X; Yu X
    Medicine (Baltimore); 2016 Feb; 95(8):e2914. PubMed ID: 26937935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion and perfusion MR parameters to assess preoperative short-course radiotherapy response in locally advanced rectal cancer: a comparative explorative study among Standardized Index of Shape by DCE-MRI, intravoxel incoherent motion- and diffusion kurtosis imaging-derived parameters.
    Fusco R; Sansone M; Granata V; Grimm R; Pace U; Delrio P; Tatangelo F; Botti G; Avallone A; Pecori B; Petrillo A
    Abdom Radiol (NY); 2019 Nov; 44(11):3683-3700. PubMed ID: 30361867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravoxel incoherent motion diffusion-weighted MRI for predicting response to neoadjuvant chemotherapy in breast cancer.
    Kim Y; Kim SH; Lee HW; Song BJ; Kang BJ; Lee A; Nam Y
    Magn Reson Imaging; 2018 May; 48():27-33. PubMed ID: 29278762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using a deep learning (DL) method.
    Qu YH; Zhu HT; Cao K; Li XT; Ye M; Sun YS
    Thorac Cancer; 2020 Mar; 11(3):651-658. PubMed ID: 31944571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment Intra-Voxel Incoherent Motion Diffusion-Weighted Imaging (IVIM-DWI) in Predicting Induction Chemotherapy Response in Locally Advanced Hypopharyngeal Carcinoma.
    Guo W; Luo D; Lin M; Wu B; Li L; Zhao Y; Yang L; Zhou C
    Medicine (Baltimore); 2016 Mar; 95(10):e3039. PubMed ID: 26962824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of intravoxel incoherent motion and dynamic contrast-enhanced MRI for predicting the early and short-term responses to chemoradiotherapy in nasopharyngeal carcinoma.
    Hou J; Yu X; Hu Y; Li F; Xiang W; Wang L; Wang H; Lu Q; Zhang Z; Zeng W
    Medicine (Baltimore); 2016 Aug; 95(35):e4320. PubMed ID: 27583847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Monoexponential, Stretched-Exponential and Intravoxel Incoherent Motion MRI Diffusion Models in Early Response Monitoring to Neoadjuvant Chemotherapy in Patients With Breast Cancer-A Preliminary Study.
    Almutlaq ZM; Wilson DJ; Bacon SE; Sharma N; Stephens S; Dondo T; Buckley DL
    J Magn Reson Imaging; 2022 Oct; 56(4):1079-1088. PubMed ID: 35156741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravoxel incoherent motion diffusion-weighted imaging for monitoring chemotherapeutic efficacy in gastric cancer.
    Song XL; Kang HK; Jeong GW; Ahn KY; Jeong YY; Kang YJ; Cho HJ; Moon CM
    World J Gastroenterol; 2016 Jun; 22(24):5520-31. PubMed ID: 27350730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the prediction value of multiparametric magnetic resonance imaging at 3 T in response to neoadjuvant chemotherapy in breast cancer.
    Minarikova L; Bogner W; Pinker K; Valkovič L; Zaric O; Bago-Horvath Z; Bartsch R; Helbich TH; Trattnig S; Gruber S
    Eur Radiol; 2017 May; 27(5):1901-1911. PubMed ID: 27651141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravoxel incoherent motion (IVIM) for response assessment in patients with osteosarcoma undergoing neoadjuvant chemotherapy.
    Baidya Kayal E; Kandasamy D; Khare K; Bakhshi S; Sharma R; Mehndiratta A
    Eur J Radiol; 2019 Oct; 119():108635. PubMed ID: 31445487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Texture analysis based on contrast-enhanced MRI can predict treatment response to neoadjuvant chemotherapy of breast cancer].
    Sun SH; Zhou CW; Zhao LY; Zhang RZ; Ouyang H
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):344-349. PubMed ID: 28535650
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer using diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging.
    Xu HD; Zhang YQ
    Neoplasma; 2017; 64(3):430-436. PubMed ID: 28253722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can FDG-PET/CT predict early response to neoadjuvant chemotherapy in breast cancer?
    Andrade WP; Lima EN; Osório CA; do Socorro Maciel M; Baiocchi G; Bitencourt AG; Fanelli MF; Damascena AS; Soares FA
    Eur J Surg Oncol; 2013 Dec; 39(12):1358-63. PubMed ID: 24120422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and MRS.
    Shin HJ; Baek HM; Ahn JH; Baek S; Kim H; Cha JH; Kim HH
    NMR Biomed; 2012 Dec; 25(12):1349-59. PubMed ID: 22566277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.